Tixiao Wang

887 total citations
18 papers, 654 citations indexed

About

Tixiao Wang is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Tixiao Wang has authored 18 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Tixiao Wang's work include Galectins and Cancer Biology (5 papers), Immune Cell Function and Interaction (4 papers) and RNA modifications and cancer (3 papers). Tixiao Wang is often cited by papers focused on Galectins and Cancer Biology (5 papers), Immune Cell Function and Interaction (4 papers) and RNA modifications and cancer (3 papers). Tixiao Wang collaborates with scholars based in China, Sweden and United States. Tixiao Wang's co-authors include Chunhong Ma, Xiaohong Liang, Lifen Gao, Xiaojia Song, Chunyang Li, Zhuanchang Wu, Xianhong Du, Zehua Wang, Siyu Tan and Leiqi Xu and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Tixiao Wang

18 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tixiao Wang China 12 290 257 128 123 120 18 654
Yitao Ou China 13 300 1.0× 121 0.5× 70 0.5× 145 1.2× 40 0.3× 19 603
Xiaoqing Jia China 11 379 1.3× 110 0.4× 173 1.4× 98 0.8× 125 1.0× 36 587
Howard E. Boudreau United States 11 333 1.1× 232 0.9× 110 0.9× 74 0.6× 121 1.0× 17 652
Arianna Marino Italy 15 378 1.3× 231 0.9× 265 2.1× 217 1.8× 188 1.6× 16 858
Meng Du China 12 375 1.3× 142 0.6× 216 1.7× 124 1.0× 139 1.2× 26 680
Shengkai Zuo China 16 279 1.0× 116 0.5× 75 0.6× 71 0.6× 62 0.5× 30 613
Weixue Tang China 13 278 1.0× 75 0.3× 160 1.3× 64 0.5× 90 0.8× 38 507
Junliang Pu China 11 243 0.8× 89 0.3× 124 1.0× 91 0.7× 32 0.3× 22 447
Xuan Luo China 15 324 1.1× 171 0.7× 170 1.3× 48 0.4× 87 0.7× 24 608

Countries citing papers authored by Tixiao Wang

Since Specialization
Citations

This map shows the geographic impact of Tixiao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tixiao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tixiao Wang more than expected).

Fields of papers citing papers by Tixiao Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tixiao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tixiao Wang. The network helps show where Tixiao Wang may publish in the future.

Co-authorship network of co-authors of Tixiao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Tixiao Wang. A scholar is included among the top collaborators of Tixiao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tixiao Wang. Tixiao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Peng, Jiali, Di Zhao, Liyun Xu, et al.. (2024). Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8+ T cell exhaustion and anti-PD-1 resistance. Cell Reports Medicine. 5(8). 101686–101686. 26 indexed citations
2.
Tian, Xuan, Xin Yan, Nan Zang, et al.. (2024). Injectable thermosensitive selenium-containing hydrogel as mesenchymal stem cell carrier to improve treatment efficiency in limb ischemia. Materials Today Bio. 25. 100967–100967. 5 indexed citations
3.
Zhang, Zhenhua, Ying Zou, Tixiao Wang, et al.. (2024). Immunometabolic changes and potential biomarkers in CFS peripheral immune cells revealed by single-cell RNA sequencing. Journal of Translational Medicine. 22(1). 925–925. 3 indexed citations
4.
Chen, Xiaotong, Yan Li, Yunxiao Wu, et al.. (2023). The hepatic GABAergic system promotes liver macrophage M2 polarization and mediates HBV replication in mice. Antiviral Research. 217. 105680–105680. 8 indexed citations
5.
Zhang, Yankun, Yu‐Chen Fan, Xiaohui Zhang, et al.. (2023). ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury. Nature Communications. 14(1). 7527–7527. 10 indexed citations
6.
Zhang, Xiaodong, Shuangjie Li, Xiaolei Ren, et al.. (2022). TIPE1 promotes liver regeneration by enhancing ROS‐FoxO1 axis mediated autophagy. FEBS Journal. 290(4). 1117–1133. 6 indexed citations
7.
Tan, Siyu, Mengzhen Li, Tixiao Wang, et al.. (2021). Transcription factor Zhx2 restricts NK cell maturation and suppresses their antitumor immunity. The Journal of Experimental Medicine. 218(9). 19 indexed citations
8.
Song, Xiaojia, Na Li, Yuan Liu, et al.. (2021). CD169-positive macrophages enhance abscopal effect of radiofrequency ablation therapy in liver cancer. Translational Oncology. 15(1). 101306–101306. 13 indexed citations
9.
Wang, Tixiao & Chunhong Ma. (2021). The hepatic macrophage pool in NASH. Cellular and Molecular Immunology. 18(8). 2059–2060. 11 indexed citations
10.
Wang, Tixiao, Jie Zhang, Na Li, et al.. (2021). Spatial distribution and functional analysis define the action pathway of Tim-3/Tim-3 ligands in tumor development. Molecular Therapy. 30(3). 1135–1148. 10 indexed citations
11.
Lin, Qinghai, Zhuanchang Wu, Xuetian Yue, et al.. (2020). ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation. EBioMedicine. 53. 102676–102676. 49 indexed citations
12.
Wang, Zehua, Liang Kong, Siyu Tan, et al.. (2020). Zhx2 Accelerates Sepsis by Promoting Macrophage Glycolysis via Pfkfb3. The Journal of Immunology. 204(8). 2232–2241. 47 indexed citations
13.
Lin, Qinghai, Zhuanchang Wu, Yankun Zhang, et al.. (2020). ZHX2 inhibits SREBP1c‐mediated de novo lipogenesis in hepatocellular carcinoma via miR‐24‐3p. The Journal of Pathology. 252(4). 358–370. 35 indexed citations
14.
Yang, Huimin, Tingting Xie, Xianhong Du, et al.. (2019). Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway. Molecular Metabolism. 23. 24–36. 146 indexed citations
15.
Tan, Siyu, Yong Xu, Zehua Wang, et al.. (2019). Tim-3 Hampers Tumor Surveillance of Liver-Resident and Conventional NK Cells by Disrupting PI3K Signaling. Cancer Research. 80(5). 1130–1142. 117 indexed citations
16.
Du, Xianhong, Zhuanchang Wu, Yong Xu, et al.. (2018). Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice. Cellular and Molecular Immunology. 16(11). 878–886. 77 indexed citations
17.
Xu, Yong, Zehua Wang, Xianhong Du, et al.. (2018). Tim‐3 blockade promotes iNKT cell function to inhibit HBV replication. Journal of Cellular and Molecular Medicine. 22(6). 3192–3201. 16 indexed citations
18.
Song, Xiaojia, Siyu Tan, Zhuanchang Wu, et al.. (2018). HBV suppresses ZHX2 expression to promote proliferation of HCC through miR‐155 activation. International Journal of Cancer. 143(12). 3120–3130. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026